| Literature DB >> 18444843 |
Philippe De Wals1, Geneviève Deceuninck, Renée-Myriam Boucher, Manale Ouakki.
Abstract
To assess the risk of Guillain-Barré syndrome (GBS) following administration of meningococcal serogroup C-CRM(197) conjugate vaccine, provincial immunization records were linked with hospital discharge records, and medical charts were reviewed. In the cohort of 1.9 million individuals (age, 2 months to 20 years), observed postvaccination frequencies of GBS were not higher than expected.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18444843 DOI： 10.1086/533469
Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079